Project Details
Description
PROJECT NARRATIVE
The crosstalk between KRas mutations and inflammatory processes drive the development and progression of
pancreatic cancer. Here we will investigate the mechanisms of how oncogenic KRas mediates the attraction of
macrophages and how this contributes to development of cancer, but also test novel approaches to block this
event. Overall our project will lead to preclinical data supporting new treatment strategies that can be
incorporated into standard of care treatment and may lead to a better outcome for patients with advanced
cancer.
Status | Active |
---|---|
Effective start/end date | 3/1/19 → 2/28/23 |
Funding
- National Cancer Institute: $357,994.00
- National Cancer Institute: $322,194.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.